Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Earnings vs. Expectations
Compare| Mar 2012* | Jun 2012* | Sep 2012* | Dec 2012* | Mar 2013* | |
| * Quarter Ending | |||||
|---|---|---|---|---|---|
| Estimated EPS($) | 0.56 | 0.10 | 0.01 | -0.50 | -0.42 |
| Reported EPS($) | 0.01 | -0.08 | -0.06 | -0.43 | NA |
| GAAP($) | 0.01 | -0.08 | -0.06 | -0.43 | NA |
| Mar 2013* | Jun 2013* | Dec 2013** | Dec 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
| Average Estimate ($) | -0.42 | -0.32 | -1.15 | 0.52 |
| Number of Analysts | 16 | 15 | 17 | 17 |
| Low Estimate ($) | -0.57 | -0.55 | -1.81 | -0.50 |
| High Estimate ($) | -0.29 | -0.13 | -0.49 | 1.93 |
| Mar 2013* | Jun 2013* | Dec 2013** | Dec 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
|---|---|---|---|---|
| Current Estimate ($) | -0.42 | -0.32 | -1.15 | 0.52 |
| 30 Days Ago ($) | -0.43 | -0.32 | -1.16 | 0.51 |
| 90 Days Ago ($) | -0.35 | -0.15 | -0.85 | 0.59 |
| Dec 2013* | Dec 2014* | Next 3 Years (per year) | Forward P/E | PEG | ||
| * Year Ending | ||||||
|---|---|---|---|---|---|---|
| MDVN | 7.96% | 89.33% | NA | NA | NA | |
